换一批Economic evaluation of bivalirudin with or without glycoprotein IIb/IIIa inhibition versus heparin with routine glycoprotein IIb/IIIa inhibition for early invasive management of acute coronary syndromes.
第一作者：
Duane S,Pinto
第一单位：
Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts 02115, USA. dpinto@bidmc.harvard.edu
作者：
主题词
急性冠状动脉综合征(Acute Coronary Syndrome);血管成形术, 气囊, 冠状动脉(Angioplasty, Balloon, Coronary);抗凝药(Anticoagulants);冠状动脉分流术(Coronary Artery Bypass);药物疗法, 联合(Drug Therapy, Combination);女(雌)性(Female);卫生保健费用(Health Care Costs);肝素(Heparin);肝素, 低分子量(Heparin, Low-Molecular-Weight);水蛭素类(Hirudins);人类(Humans);男(雄)性(Male);中年人(Middle Aged);肽碎片(Peptide Fragments);血小板糖蛋白GPⅡb-Ⅲa复合物(Platelet Glycoprotein GPIIb-IIIa Complex);前瞻性研究(Prospective Studies);重组蛋白质类(Recombinant Proteins);危险因素(Risk Factors);时间因素(Time Factors);治疗结果(Treatment Outcome);美国(United States)
DOI
10.1016/j.jacc.2008.08.021
PMID
19022155
发布时间
2025-04-28
- 浏览21
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
